Abstract
Since May 2022, Mpox has rapidly spread globally and been posing new challenges. There is no specific treatment drug for monkeypox (Mpox), and how to avoid cross infection has become the key to the prevention and control of the Mpox epidemic. However, current guidelines lack systematic recommendations for reducing Mpox transmission risk in medical institutions. Therefore, the National Training Center of Hospital Infection in China collaborated with 64 domestic experts to sort out relevant issues and urgently released the consensus of Chinese experts on Mpox healthcare-associated Infection prevention and control. The main content includes an overview of the Mpox epidemic, pathogenic characteristics, epidemiology, early identification and diagnosis, infection prevention and control strategies in medical institutions, and healthcare-associated infection prevention and control measures, aiming to strengthen healthcare-associated infection prevention and control of Mpox and reduce cross infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
